Triglyceride Variability and Risk of Adverse Cardiovascular Outcomes-Results from the ACCORD Trial

被引：0
作者：
Nuyujukian, Daniel S.
Zhou, Jin
Koska, Juraj
Reaven, Peter
机构：
来源：
DIABETES | 2023年 / 72卷
关键词：
D O I：
10.2337/db23-1240-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1240-P
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Adverse pregnancy outcomes and cardiovascular risk factor management
    Mehta, Puja K.
    Minissian, Margo
    Merz, C. Noel Bairey
    SEMINARS IN PERINATOLOGY, 2015, 39 (04) : 268 - 275
  • [32] Body-Weight Variability and Risk of Cardiovascular Outcomes in Type 1 Diabetes: Results from the DCCT/EDIC Studies
    Petria, Iulia
    Albuquerque, Samuel
    Varoquaux, Gael
    Vie, Jill-Jenn
    Velho, Gilberto
    Perseghin, Gianluca
    Roussel, Ronan
    Potier, Louis
    DIABETES, 2022, 71
  • [33] Maintained intentional weight loss reduces cardiovascular outcomes: results from the Sibutramine Cardiovascular OUTcomes (SCOUT) trial
    Caterson, I. D.
    Finer, N.
    Coutinho, W.
    Van Gaal, L. F.
    Maggioni, A. P.
    Torp-Pedersen, C.
    Sharma, A. M.
    Legler, U. F.
    Shepherd, G. M.
    Rode, R. A.
    Perdok, R. J.
    Renz, C. L.
    James, W. P. T.
    DIABETES OBESITY & METABOLISM, 2012, 14 (06) : 523 - 530
  • [34] Plasma Osteopontin Levels and Adverse Cardiovascular Outcomes in the PEACE Trial
    Abdalrhim, Ahmed D.
    Marroush, Tariq S.
    Austin, Erin E.
    Gersh, Bernard J.
    Solak, Nusret
    Rizvi, Syed A.
    Bailey, Kent R.
    Kullo, Iftikhar J.
    PLOS ONE, 2016, 11 (06):
  • [35] Rationale design, and methods of the action to control cardiovascular - Risk in diabetes (Accord) trial - Introduction
    Byington, Robert P.
    Genuth, Saul
    Friedewald, William T.
    Simons-Morton, Denise G.
    AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (12A) : 1I - 3I
  • [36] Blood pressure variability predicts adverse events and cardiovascular outcomes in SPRINT
    Mezue, Kenechukwu
    Goyal, Abhinav
    Pressman, Gregg S.
    Matthew, Roy
    Horrow, Jay C.
    Rangaswami, Janani
    JOURNAL OF CLINICAL HYPERTENSION, 2018, 20 (09) : 1247 - 1252
  • [37] Effects of Cardiac Autonomic Dysfunction on Mortality Risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial
    Pop-Busui, Rodica
    Evans, Gregory W.
    Gerstein, Hertzel C.
    Fonseca, Vivian
    Fleg, Jerome L.
    Hoogwerf, Byron J.
    Genuth, Saul
    Grimm, Richard H.
    Corson, Marshall A.
    Prineas, Ronald
    DIABETES CARE, 2010, 33 (07) : 1578 - 1584
  • [38] Severe hypoglycemia monitoring and risk management procedures in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial
    Bonds, Denise E.
    Kurashige, Ella Mae
    Bergenstal, Richard
    Brillon, David
    Domanski, Michael
    Felicetta, James V.
    Fonseca, Vivian A.
    Hall, Kathleen
    Hramiak, Irene
    Miller, Michael E.
    Osei, Kwame
    Simons-Morton, Denise G.
    AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (12A) : 80I - 89I
  • [39] The ACCORD (Action to Control Cardiovascular Risk in Diabetes) Lipid Trial What we learn from subgroup analyses
    Ginsberg, Henry N.
    DIABETES CARE, 2011, 34 : S107 - S108
  • [40] Association between mean systolic blood pressure and cardiovascular outcomes in diabetes mellitus: ACCORD trial
    Yeboah, Joseph
    Byington, Bob
    Bertoni, Alain
    JOURNAL OF HUMAN HYPERTENSION, 2018, 32 (02) : 167 - 169
12345